During the past decade, Fundacao Antonio Prudente conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fundacao Antonio Prudente" #1 sponsor was "Pfizer" with 3 trials, followed by "International Atomic Energy Agency" with 2 trials sponsored, "Aragon Pharmaceuticals, Inc." with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored and "Janssen Sciences Ireland UC" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fundacao Antonio Prudente" #1 collaborator was "Dr Cipto Mangunkusumo General Hospital" with 2 trials as a collaborator, "Hospital A.C. Camargo" with 2 trials as a collaborator, "Cancer Trials Ireland" with 1 trials as a collaborator, "Catholic University of the Sacred Heart" with 1 trials as a collaborator and "Centre Anti Cancer Hopital Frantz Fanon" with 1 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Fundacao Antonio Prudente" are "Carcinoma, Non-Small-Cell Lung" (2 trials), "Cancer" (1 trials), "Chemotherapy-induced Diarrhea" (1 trials), "Glioblastoma Multiforme" (1 trials) and "Kidney Neoplasms" (1 trials). Many other conditions were trialed in "Fundacao Antonio Prudente" in a lesser frequency.

Most popular intervention types in "Fundacao Antonio Prudente" are "Drug" (7 trials), "Radiation" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "PF-02341066" (2 trials), "Radiotherapy" (2 trials), "ADT (Standard of Care)" (1 trials), "Apalutamide" (1 trials) and "Atezolizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fundacao Antonio Prudente" are 8 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Fundacao Antonio Prudente". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Fundacao Antonio Prudente, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Fundacao Antonio Prudente, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".